FI865163A - Peptider innehaollande grupper av sulfatester. - Google Patents

Peptider innehaollande grupper av sulfatester. Download PDF

Info

Publication number
FI865163A
FI865163A FI865163A FI865163A FI865163A FI 865163 A FI865163 A FI 865163A FI 865163 A FI865163 A FI 865163A FI 865163 A FI865163 A FI 865163A FI 865163 A FI865163 A FI 865163A
Authority
FI
Finland
Prior art keywords
sulfatester
grupper
peptider
innehaollande
peptides
Prior art date
Application number
FI865163A
Other languages
English (en)
Other versions
FI865163A0 (fi
FI86193C (fi
FI86193B (fi
Inventor
James Donald Rosamond
Original Assignee
Pennwalt Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pennwalt Corp filed Critical Pennwalt Corp
Publication of FI865163A0 publication Critical patent/FI865163A0/fi
Publication of FI865163A publication Critical patent/FI865163A/fi
Application granted granted Critical
Publication of FI86193B publication Critical patent/FI86193B/fi
Publication of FI86193C publication Critical patent/FI86193C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/595—Gastrins; Cholecystokinins [CCK]
    • C07K14/5955—Gastrins; Cholecystokinins [CCK] at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
FI865163A 1985-12-19 1986-12-17 Foerfarande foer framstaellning av farmaceutiskt anvaendbar peptid. FI86193C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US81094885A 1985-12-19 1985-12-19
US81094885 1985-12-19
US93211986A 1986-11-18 1986-11-18
US93211986 1986-11-18

Publications (4)

Publication Number Publication Date
FI865163A0 FI865163A0 (fi) 1986-12-17
FI865163A true FI865163A (fi) 1987-06-20
FI86193B FI86193B (fi) 1992-04-15
FI86193C FI86193C (fi) 1992-07-27

Family

ID=27123406

Family Applications (1)

Application Number Title Priority Date Filing Date
FI865163A FI86193C (fi) 1985-12-19 1986-12-17 Foerfarande foer framstaellning av farmaceutiskt anvaendbar peptid.

Country Status (12)

Country Link
EP (1) EP0226217B1 (fi)
JP (1) JP2569316B2 (fi)
AT (1) ATE100821T1 (fi)
AU (1) AU596388B2 (fi)
DE (2) DE3689585T2 (fi)
DK (1) DK608186A (fi)
ES (1) ES2000108T3 (fi)
FI (1) FI86193C (fi)
IE (1) IE62659B1 (fi)
IL (1) IL80971A (fi)
NO (1) NO865132L (fi)
NZ (1) NZ218607A (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5086042A (en) * 1985-12-19 1992-02-04 Fisons Corporation Peptides with sulfate ester groups
US4808701A (en) * 1987-03-30 1989-02-28 Hoffmann-La Roche Inc. Cyclic peptides having appetite regulating activity
ZA878594B (en) * 1987-05-27 1989-07-26 Pennwalt Corp Peptides with sulfate ester groups
ZA883929B (en) * 1987-06-22 1990-02-28 Hoffmann La Roche Cholecystokinin analogs for controlling appetite
US5182263A (en) * 1988-04-25 1993-01-26 Hoffmann-La Roche Inc. Analogs of tyrosine sulfate or tyrosine phosphate containing peptides
JPH0219396A (ja) * 1988-07-06 1990-01-23 Shionogi & Co Ltd 新規ペプチドおよびそれを含有する脳機能改善剤
FR2634763B1 (fr) * 1988-08-01 1991-07-12 Inst Nat Sante Rech Med Amino-acides et peptides presentant un residu tyrosine modifiee, leur preparation et leur application comme medicaments
US5631230A (en) * 1989-09-21 1997-05-20 Arizona Technology Development Corporation Receptor selective analogues of cholecystokinin-8
US5502164A (en) * 1989-11-27 1996-03-26 Fisons Corporation Peptide compounds having therapeutic activity
AU644128B2 (en) * 1989-11-27 1993-12-02 Astra Aktiebolag Hexapeptides with sulphate ester groups
JPH06506941A (ja) * 1991-04-24 1994-08-04 ワーナー−ランバート・コンパニー α−置換アミノ酸含有ＣＣＫ類似体
MX9207458A (es) * 1991-12-20 1993-11-01 Fisons Corp Compuestos de peptido que tienen actividad terapeutica.
JP2007506730A (ja) * 2003-09-24 2007-03-22 ベクタ・リミテッド ペンタガストリンを含む胃酸分泌刺激用経口組成物
CN103833593B (zh) * 2014-03-21 2016-08-17 四川什邡市三高生化实业有限公司 一种n-(9-芴甲氧羰基)-o-叔丁基-l-酪氨酸的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4842633A (fi) * 1971-09-30 1973-06-21
JPS5130069A (ja) * 1974-09-05 1976-03-13 Nogyo Kikaika Kenkyusho Kokumotsushuyobukuro
DD128973B1 (de) * 1976-11-29 1979-11-28 Hartmut Niedrich Verfahren zur herstellung von peptiden,die tyrosinsulfat enthalten
US4351829A (en) * 1980-09-26 1982-09-28 Farmitalia Carlo Erba Spa Use of polypeptides as analgesic drugs
JPS57146745A (en) * 1981-03-09 1982-09-10 Amano Pharmaceut Co Ltd Peptide amidosulfate ester derivative and its preparation
JPS5978151A (ja) * 1982-10-27 1984-05-04 Amano Pharmaceut Co Ltd 新規ペプチド及びこれを含有する抗精神分裂病薬剤
JPS6028992A (ja) * 1983-07-20 1985-02-14 Amano Pharmaceut Co Ltd ペプチド及びこれを含有する抗精神分裂病薬剤
DK489683A (da) * 1982-10-27 1984-04-28 Amano Pharma Co Ltd Fremgangsmaade til fremstilling af peptider
US4490364A (en) * 1983-05-20 1984-12-25 The Salk Institute For Biological Studies CCK Agonists II
JPS60100595A (ja) * 1983-11-04 1985-06-04 Amano Pharmaceut Co Ltd 新規ペプチド
JPS60194000A (ja) * 1984-03-14 1985-10-02 Amano Pharmaceut Co Ltd ペプチドアミドスルフエ−トエステル
EP0161468A3 (en) * 1984-05-07 1988-10-26 Pennwalt Corporation Process for the solid phase synthesis of peptides which contain sulfated tyrosine
JPS62126198A (ja) * 1985-11-26 1987-06-08 Amano Pharmaceut Co Ltd ペプチドアミドスルフエ−トエステル

Also Published As

Publication number Publication date
DE3689585D1 (de) 1994-03-10
EP0226217A2 (en) 1987-06-24
AU596388B2 (en) 1990-05-03
DK608186A (da) 1987-08-20
DK608186D0 (da) 1986-12-17
IL80971A (en) 1991-12-12
NZ218607A (en) 1989-10-27
ES2000108A4 (es) 1987-12-01
IE863300L (en) 1987-06-19
DE226217T1 (de) 1988-01-14
EP0226217A3 (en) 1989-05-24
JPS62228100A (ja) 1987-10-06
DE3689585T2 (de) 1994-07-07
AU6671486A (en) 1987-06-25
EP0226217B1 (en) 1994-01-26
FI865163A0 (fi) 1986-12-17
NO865132D0 (no) 1986-12-17
FI86193C (fi) 1992-07-27
JP2569316B2 (ja) 1997-01-08
FI86193B (fi) 1992-04-15
ES2000108T3 (es) 1994-12-16
IE62659B1 (en) 1995-02-22
IL80971A0 (en) 1987-03-31
NO865132L (no) 1987-06-22
ATE100821T1 (de) 1994-02-15

Similar Documents

Publication Publication Date Title
FI865163A0 (fi) Peptider innehaollande grupper av sulfatester.
ZA871860B (en) Transglutaminase inhibitors
DE69233115D1 (de) Weitere therapeutische Verwendungen von L-Methionine und Zusammensetzungen
PH27413A (en) 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasopastic
IE873084L (en) Peptides with sulfate ester groups
ZA905505B (en) Hemoregulatory peptides
GR3029489T3 (en) Use of leflunomid for the inhibition of interleukin 8.
GR3017321T3 (en) Use of amino acids for the protection of and metabolic recovery of ischemic cardiac tissue.
IT1271567B (it) Procedimento per l'ulteriore trattamento di salcicce
EP0269017A3 (en) Therapeutic combination of free-radical scavenger or metabolic inhibitor and biologically active protein
ATE67479T1 (de) Ester von salsalat mit guajakol zur behandlung von phlogistischen bronchopneumopathien.
DE3782006T2 (de) Peptide.
ZA898553B (en) The use of ethylenediaminetetraacetic acid as inhibitor of calcium/calmodulin-dependent protein kinase ii or of protein kinase c
EP0382180A3 (en) Derivatives of thiazolidine-4-carboxylic acid, its preparation and pharmaceutical compositions containing it
GB2220652B (en) Treatment of pastures
GR3029492T3 (en) Use of leflunomid for the inhibition of interleukin 1 alpha.
DE3689850D1 (de) Peptide und deren Verwendung in der Therapie.
ATE68175T1 (de) Verfahren zur herstellung von l,l oder d,d oder racemat n6 benzyloxycarbonyl 2,6 diaminopimelinsaeuremonoamid.
IT8419056A1 (it) Procedimento per l'isolamento di L-amminoacidi

Legal Events

Date Code Title Description
MM Patent lapsed
BB Publication of examined application
MM Patent lapsed

Owner name: FISONS CORPORATION